Outlook Therapeutics Inc (OTLK)
7.90
+0.37
(+4.91%)
USD |
NASDAQ |
May 24, 16:00
7.91
+0.01
(+0.13%)
After-Hours: 20:00
Outlook Therapeutics Free Cash Flow: -58.26M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
March 31, 2024 | -58.26M |
December 31, 2023 | -47.10M |
September 30, 2023 | -42.97M |
June 30, 2023 | -40.48M |
March 31, 2023 | -48.37M |
December 31, 2022 | -54.59M |
September 30, 2022 | -56.67M |
June 30, 2022 | -55.41M |
March 31, 2022 | -54.51M |
December 31, 2021 | -51.92M |
September 30, 2021 | -54.25M |
June 30, 2021 | -57.34M |
March 31, 2021 | -43.10M |
December 31, 2020 | -38.44M |
September 30, 2020 | -31.79M |
June 30, 2020 | -25.65M |
March 31, 2020 | -30.01M |
December 31, 2019 | -29.18M |
Date | Value |
---|---|
September 30, 2019 | -32.73M |
June 30, 2019 | -36.44M |
March 31, 2019 | -34.69M |
December 31, 2018 | -36.09M |
September 30, 2018 | -35.82M |
June 30, 2018 | -26.11M |
March 31, 2018 | -23.11M |
December 31, 2017 | -19.55M |
September 30, 2017 | -15.80M |
June 30, 2017 | -26.55M |
March 31, 2017 | -37.34M |
December 31, 2016 | -40.19M |
September 30, 2016 | -46.58M |
June 30, 2016 | -50.19M |
March 31, 2016 | -47.22M |
December 31, 2015 | -44.46M |
September 30, 2015 | -36.28M |
Free Cash Flow Range, Past 5 Years
-58.26M
Minimum
Mar 2024
-25.65M
Maximum
Jun 2020
-44.46M
Average
-45.10M
Median
Free Cash Flow Benchmarks
Cutera Inc | -161.47M |
Actinium Pharmaceuticals Inc | -39.72M |
GT Biopharma Inc | -10.11M |
Karyopharm Therapeutics Inc | -117.73M |
Marinus Pharmaceuticals Inc | -113.98M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -19.27M |
Cash from Financing (Quarterly) | 56.14M |
Free Cash Flow Per Share (Quarterly) | -1.350 |
Free Cash Flow Yield | -55.52% |